eToro Group (ETOR) CFO details extensive stock option holdings
Filing Impact
Filing Sentiment
Form Type
3
Rhea-AI Filing Summary
eToro Group Ltd. CFO Shani Meron has filed an initial Form 3 detailing existing stock option holdings. The filing lists multiple direct options to purchase Class A and Class B common shares with exercise prices of $6.7000 and $17.5000 and expiration dates from 2029 through 2034.
Footnotes state that some options are fully vested and immediately exercisable, while others vest in scheduled quarterly installments through 2029. Class B common shares are convertible into Class A common shares at any time at the holder’s option, so these derivative positions all relate economically to Class A equity.
Positive
- None.
Negative
- None.
Insider Trade Summary
12 transactions reported
Mixed
12 txns
Insider
Shani Meron
Role
CFO
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Options to purchase Class A common shares | -- | -- | -- |
| holding | Options to purchase Class A common shares | -- | -- | -- |
| holding | Options to purchase Class A common shares | -- | -- | -- |
| holding | Options to purchase Class A common shares | -- | -- | -- |
| holding | Options to purchase Class A common shares | -- | -- | -- |
| holding | Options to purchase Class A common shares | -- | -- | -- |
| holding | Options to purchase Class B common shares | -- | -- | -- |
| holding | Options to purchase Class B common shares | -- | -- | -- |
| holding | Options to purchase Class B common shares | -- | -- | -- |
| holding | Options to purchase Class B common shares | -- | -- | -- |
| holding | Options to purchase Class B common shares | -- | -- | -- |
| holding | Options to purchase Class B common shares | -- | -- | -- |
Holdings After Transaction:
Options to purchase Class A common shares — 3,813 shares (Direct);
Options to purchase Class B common shares — 8,352 shares (Direct)
Footnotes (1)
- These options are fully vested and immediately exercisable. Includes options to purchase 40,000 Class A common shares ("Class A Options"), of which 27,500 Class A Options are vested and 2,500 Class A Options shall vest on April 1, 2026 and following each subsequent 3-month period thereafter until April 1, 2027. Includes 40,000 Class A Options, of which 4,000 Class A Options vested on January 1, 2026, and 3,000 Class A Options shall vest following each subsequent 3-month period thereafter, until January 1, 2029. Class B common shares are convertible into Class A common shares at any time at the holder's option. Includes options to purchase 40,000 Class B common shares ("Class B Options"), of which 27,500 Class B Options are vested and 2,500 Class B Options shall vest on April 1, 2026 and following each subsequent 3-month period thereafter until April 1, 2027. Includes 40,000 Class B Options, of which 4,000 Class B Options vested on January 1, 2026, and 3,000 Class B Options shall vest following each subsequent 3-month period thereafter, until January 1, 2029.
FAQ
What does eToro (ETOR) CFO Shani Meron report in this Form 3?
Shani Meron reports existing holdings of stock options in eToro Group Ltd. The options cover Class A and Class B common shares, with exercise prices of $6.7000 and $17.5000 and expirations stretching from 2029 to 2034.
Are the eToro (ETOR) CFO’s options reported on Form 3 vested?
Some of the CFO’s options are already fully vested and immediately exercisable. Others follow quarterly vesting schedules, with specified tranches vesting on dates such as April 1, 2026 and continuing in three‑month intervals through January 1, 2029, according to the footnotes.
What are the exercise prices of the eToro (ETOR) CFO’s reported options?
The reported options have exercise prices of $6.7000 and $17.5000 per share. These strike levels apply across various grants on both Class A and Class B common shares, each with its own expiration date between 2029 and 2034.
How long do the eToro (ETOR) CFO’s options reported on Form 3 remain outstanding?
The options listed remain outstanding until expiration dates ranging from April 15, 2029 through November 26, 2034. Each grant has a specific maturity, providing a multi‑year window during which the CFO can choose to exercise, subject to vesting.